Adn-388 |verified| Jun 2026

The investigation into ADN-388 serves as a reminder of the complexities and mysteries still present in scientific research. As we continue to explore the unknown, we may uncover:

CT-388 is a dual GLP-1/GIP receptor agonist, meaning it targets two different hormone receptors to regulate metabolism. Its unique "signal-biased" design sets it apart from existing therapies: ADN-388